Virus In Babies May
Cause Asthma Later On
St. Louis, July 15, 2002 —- While most scientists believe that allergies
cause asthma, researchers at Washington University School of Medicine in
St.Louis are uncovering a second potential cause for this common respiratory
illness. Their new model suggests that a viral infection in the first years
of life may leave a lasting mark on the immune system, causing chronic
respiratory problems later on. "While the allergic response may increase
during an asthma attack, our research suggests that the anti-viral response
also increases," says Michael J. Holtzman, M.D., the Selma and Herman Seldin
Professor of Medicine and professor of cell biology and physiology. "We
think that a virus in infancy or childhood creates a hit-and-run effect,
where a brief infection causes permanent changes in the body's anti-viral
system."
Holtzman led the study, which appears in the July 15 issue of the Journal of
Clinical Investigation.
The most common cause of lower respiratory illness in children is
paramyxoviral infection, which often results in chronic wheezing regardless
of whether the child develops allergies. But researchers have yet to figure
out how the short-term influence of this viral infection leads to a
long-term condition of respiratory inflammation and distress. Holtzman's
team examined mice with bronchiolitis – inflamed airways – caused by
paramyxoviral infection. The mouse disease mimics paramyxoviral infection in
humans. These mice responded immediately to the infection – immune cells
flooded the lining of the respiratory tract, attacking infectious cells and
inflaming the tissues. Weeks after infection, the airways of the lung
remained extremely sensitive, or hyperreactive, and the airway lining became
populated with mucus-producing cells. Each of these changes – airway
hyperreactivity and cellular remodeling – lasted for at least one year and
perhaps indefinitely. "Since each of these changes also is a long-term
symptom of asthma, these findings provide a link between the response to
viral infection and the development of asthma," says Holtzman. Uninfected
mice that instead were exposed to a common experimental allergen, called
ovalbumin, also developed similar inflammation of the airways, but these
mice recovered by themselves within two and a half months.
To see what happens if the initial airway response was prevented, the
researchers examined mice lacking the gene that encodes one of the main
proteins that control immune-cell traffic, intercellular adhesion molecule-1
(ICAM-1). As expected, mice lacking ICAM-1 that were infected with this
virus were initially healthier than their normal counterparts, with far less
airway inflammation, less weight loss and lower mortality rates.
Interestingly, though, these genetically altered mice still developed
chronic asthma-like changes similar to normal mice – they reached the same
level of airway hyperreactivity and mucus-producing cells as normal mice by
11 weeks after infection.
The team also discovered that mice treated with glucocorticoid, a common
anti-asthma medication, before cellular remodeling began were at least
partially protected from the chronic effects of viral infection.
"Our findings raise the possibility that asthma not only resembles a
persistent anti-viral response, but may actually be caused by one," says
Holtzman. "These results in mice provide a further basis for determining
exactly how similar events may develop in children and adults with asthma."
Reference: Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral
induction of a chronic asthma phenotype and genetic segregation from the
acute response. Journal of Clinical Investigation, Vol. 110, pg. 165 – 175,
July 15, 2002.
Funding from the National Heart, Lung and Blood Institute, the American Lung
Association, the Martin Schaeffer Fund and the Alan A. and Edith L. Wolff
Charitable Trust supported this research.

The thoracic society's webpage
http://www.brit-thoracic.org.uk/
Susan, AVN Australia
Study links childhood vaccines to 'huge' increase in allergies
Pulse; Tonbridge; Dec 9, 2002;
Patients immunised with vaccines included in the UK childhood immunisation
schedule are 14 times more
likely to be diagnosed with asthma than unvaccinated children, a study of
29,000 patients suggests.
Full Text:
Copyright CMP Information Ltd. Dec 9, 2002
By Rob Gough
Patients immunised with vaccines included in the UK childhood immunisation
schedule are 14 times more
likely to be diagnosed with asthma than unvaccinated children, a study of
29,000 patients suggests.
The researchers said although the study found a link between the vaccines
and asthma, it was 'unlikely' to
be causal. The cohort study compared doctor-diagnosed asthma and eczema
rates in unvaccinated children with those immunised against diphtheria,
polio, pertussis, tetanus and MMR.
Children who had been vaccinated - some 96 per cent -were 14 times more
likely to be diagnosed with asthma and 9.4 times more likely to be diagnosed
with eczema than unvaccinated children, the study showed. Study co-author Dr
Richard Hubbard, senior lecturer in respiratory medicine at the University
of Nottingham, played down the findings, arguing there were 'significant
interactions' between vaccination and consulting behaviour. He said: 'The
problem is people who don't go to the doctor's don't get diagnoses of asthma
and don't get vaccinated. In the unvaccinated group you will always see a
lower risk of asthma.'
The study, presented last week at the British Thoracic Society winter
meeting in London, found no association between the vaccine dose response
and allergies, making a link between current vaccination policy and
allergies 'very unlikely', said Dr Hubbard.
Dr David Bellamy, a GP in Bournemouth, Dorset, and a committee member of the
General Practice Airways
Group, said the study findings were 'pretty startling'. He said: 'A 14-fold
rise is a pretty huge increase. If these findings are true the implications
are somewhat worrying.' He added other factors such as maternal history
needed to be considered before drawing any firm conclusions.
Dr Chris Cates, editor of the Cochrane Airways Group and a GP in Bushey,
Hertfordshire, said that he was
unaware of any previous link between vaccinations and asthma.
He added: 'What I would not do is say this proves that vaccination causes
asthma. Trying to untangle whether vaccinations have a role in this is
incredibly difficult. 'If people consult more they are more likely to get
diagnosed.'

http://story.news.yahoo.com/news?
tmpl=story&u=/ap/20030225/ap_on_he_me/children_pollution_5
EPA Shows Pollution Risks to Children
Mon Feb 24, 8:40 PM ET Add Health - AP to My Yahoo!
By JOHN HEILPRIN, Associated Press Writer
WASHINGTON - Children are getting asthma at more than double the rate two
decades ago, and one of every dozen women of childbearing age has blood
mercury levels that could hinder brain development in a fetus, the
Environmental Protection Agency (news - web sites) said Monday.
EPA's report, only its second exhaustive roundup on environmental hazards to
children's health, shows success in areas where the government has taken
aggressive action, such as reductions in levels of children's blood lead
poisoning and children's exposure to secondhand smoke.
EPA Administrator Christie Whitman said the agency has done a lot to
"improve the environment for children where they live, learn and play."
Between 1980 and 1995, the report says, the percentage of children with
asthma doubled, from 3.6 percent in 1980 to 7.5 percent in 1995. The
percentage dropped in 1996 to about 6 percent, but by 2001 it had risen
again, this time to 8.7 percent: 6.3 million children.
Researchers don't know precisely why childhood asthma is increasing, but a
number of factors in air quality, both outdoors and indoors, have been
studied. Those varied factors include exposure to dust
mites, cockroaches, pesticides, tobacco smoke, ozone and soot. The EPA says
its officials are intent on examining the role of indoor air pollutants
especially, since they note modest improvements in the numbers of children
exposed to several outdoor air pollutants since 1990.
About 5 million women — 8 percent of those at the childbearing ages of 16 to
49 — had at least 5.8 parts per billion of mercury in their blood as of
2000, the report says. EPA officials said this is the first time this kind
of data has been measured. EPA has found that children born to women with
blood concentrations
of mercury above 5.8 parts per billion are at some risk of adverse health
effects, including reduced developmental IQ and problems with motor skills
such as eye-hand coordination.
Mercury, a naturally occurring metal, is a persistent pollutant that
accumulates in fish and becomes more concentrated as it moves up the food
chain. The three major sources for mercury emissions have been power plants
and municipal waste and medical waste incinerators. EPA has been regulating
since the late 1990s mercury dumped in water and air from municipal waste
and medical waste incinerators and considers it another success to have
reduced levels emitted from each of those sources by 90 percent, EPA
spokesman Joe Martyak said.
The agency is writing regulations for mercury emitted from coal-fired power
plants that are due to be completed in the next two years and are scheduled
to take effect by 2007. The number of children with elevated levels of lead
in their blood was 4.7 million in 1978 but had plunged to about 300,000 in
2000, the report says. EPA attributes most of that success to the phaseout
of lead in gasoline between 1973 and 1995 and the reduction in the number of
homes with lead-based paint from 64 million in 1990 to 38 million in 2000.
The number of children whose blood levels showed effects from secondhand
smoke declined by about one-fifth to one-half between 1988 and 2000,
depending on levels of exposure. Those figures are obtained
by tracking the amount of cotinine, a breakdown product of nicotine in
blood.
On the Net: EPA: http://www.epa.gov

Warning on asthma medication
http://news.com.au/common/printpage/0,6093,6064153,00.html
02Mar03
PARENTS of children taking inhaled steroids to treat asthma have been warned
to monitor them carefully after three children suffered severe side-effects.
The children required intensive hospital treatment after experiencing
adrenal crises following long-term, high doses of the corticosteroid
fluticasone.
Adrenal crisis is a potentially deadly condition if not treated, resulting
from an extreme lack of adrenocortical hormones. Symptoms are characterised
by seizures, vomiting, lethargy and hypoglycaemia, or low levels of glucose
in the blood. Patients can appear to be in shock or coma.
The cases, documented in the Medical Journal of Australia tomorrow, are the
country's first recorded cases of adrenal crises related to inhaled
steroids. They follow widespread concern and reports of adverse reactions,
including deaths, overseas. The patients included a seven-year-old boy, a
four-year-old boy and a 10-year-old boy who suffered a seizure after
24-hours of vomiting. All three developed problems after they became sick
with another infection.
"Our case series further highlights the potential for the systemic activity
of ICS (inhaled corticosteroids) to manifest as an acute adrenal crisis,"
the report concludes. Fluticasone, one of the newer ICS medicines, was most
likely to cause adrenal problems because of its high potency, said the
authors, from Sydney's Westmead Hospital. However, all inhaled
corticosteroids had been shown to produce adrenal suppression in children.
The report said screening for adrenal problems in children receiving high
doses of corticosteroids was difficult, and the best approach was to alert
parents to warning signs. These included lethargy, vomiting, stomach pains
or seizures. "Parents of children taking high doses of inhaled
corticosteroids should be alerted to the clinical features of adrenal
insufficiency," the authors warned.
"If suspected, prompt medical assessment should be arranged. "Prompt
recognition and treatment ... may be lifesaving." There was a suggestion the
children had been over-treated, although some children may be more
susceptible to suffering an adverse reaction than others, the authors
noted. They also said a UK survey found around 20 per cent of patients who
suffered adrenal crises where later shown not to have had asthma. The
medication was also inappropriate for recurrent coughs and viral wheezing.
Endocrinologist Dr Kim Donaghue, of Westmead Hospital, said parents
shouldn't panic and take their children off the medication, which was proven
effective in treating asthma. "You've got the two spectrums in asthma -
you've got the children who aren't on sufficient medication and then there's
a group who are probably on too much," she said. "If parents are not sure
they should have it assessed." In a joint letter to the MJA, a group of
seven Victorian asthma specialists said doctors could be over-prescribing
corticosteroids because of a discrepancy between product information and
national asthma guidelines.
They said current product information recommended a maximum daily dose of
1,000 mcg of fluticasone while the National Asthma Council set 500 mcg as
the upper daily limit. The letter said a recent study of 62 emergency
patients showed almost a third of those using fluticasone were taking 1,000
mcg daily.
Nineteen per cent were taking more than 1,500 mcg. "Our findings show that
in some patients the risks associated with the use of ICS are likely to be
compounded by using them at higher doses than recommended," they wrote.
This report appears on news.com.au.

http://story.news.yahoo.com/news?
tmpl=story&u=/nm/20030814/hl_nm/asthma_chickenpox_dc
Asthma Doesn't Hinder Chickenpox Vaccine
NEW YORK (Reuters Health) - Asthma or the steroid inhalers used to treat it
seem to have no bearing on how the chickenpox, or varicella, vaccine works,
new research suggests.
In contrast, steroids taken orally do seem to raise the risk of vaccine
failure, the findings in the journal Pediatrics indicate. A 1996 chickenpox
outbreak raised concerns that the vaccine may not work as well in
asthmatics. In that outbreak, which occurred among vaccinated children,
asthmatics were seven times more likely to get chickenpox than
non-asthmatics, Dr. Robert T. Chen, from the U.S. Centers for Disease
Control and Prevention (news - web sites) in Atlanta, and colleagues note.
To determine if asthma really is tied to vaccine failure, the researchers
analyzed vaccination data for nearly 90,000 children enrolled at two health
maintenance organizations.
Although several children did develop chickenpox despite being vaccinated,
asthma and inhaled steroid use were not identified as risk factors for
vaccine failure. Oral steroids, however, were associated with vaccine
failure, but only when these drugs were prescribed after, not before,
vaccination.
"The previous finding of asthma as a risk factor for vaccine failure may be
attributable" to the fact that the study didn't account for the use of oral
steroids, the investigators conclude. SOURCE:
Pediatrics, August 2003.

West J Med 1987 Sep;147(3):341
Asthma and urticaria after hepatitis B vaccination.
Lohiya G
To the editor:
In accordance with the recommendation of the Centers for Disease Control,
20ug of plasma-derived hepatitis B vaccine (HeptavaxB lot 2445H) was
administered to a serosusceptible 31 year-old employee in a high risk
occupation. Within 30 minutes generalized pruritus, dyspnea, urticaria, and
infraorbital edema developed (THINK allergic shiners!!). Extensive
expiratory rhonchi were present in both lungs. She was given 0.3ml
epinephrine 1:1000 dilution subcutaneously. Her symptoms partially
resolved, and the smae dose of epinephrine had to be repeated four hours
later. She was
prescribed diphenhydramine hydrochloride, 25 mg as needed, and hydroxyzine
hydrochloride, 25 mg at bedtime. This lead to significant relief the next
day. The patient had a leukocyte count of 8500 per uL with 12 % eosinophils
and raised total serum IgElevel. On questioning, she revealed that she had
experienced a similar but less severe reaction to the vaccine's first dose
four weeks earlier, when dyspnea and generalized itching developed, which
were relieved by an injection of diphenhydramine by her personal
physician. She had totally forgotten the link between the vaccine
and the reaction. She said she did not have other allergen exposures such as
bee sting, new perfume, new clothes, chemical exposures or the like.
The patient has not been given the third dose of vaccine. She has remained
negative for Hepatitis B surface antibody and has not acquired the hepatitis
B surface antibody or Hepatitis B core antibody (THE VACCINE DID NOT LEAD TO
IMMUNITY). She had a history of bronchial asthma and allergy to sulfoamides
but no history of atopic dermatitis, allergic rhinitis, or uticaria. She
had been assymptomatic for several days before both vaccine doses.
HeptavaxB contains inactivated hepatitis B surface antigen, an alum
adjuvant, and thimerosal, a preservative. Based on literature review,
thimerosal was considered to be the inciting allergen in this
case. Thimerosal has produced ocular allergy through contact lens solutions
and eye creams as well as cutaneous and system allergy. Caution should be
exercised in administering HeptavaxB to allergic to other vaccines or
medicines containing thimerosal. Thimerosal is also present in the yeast
derived hepatitis B vaccine (Recombivax-HB).
My son has had Reactive Airways only four times in his life--after his3rd
DPT and Hib at 7 mos, after his MMR and Hib at 17 months, after his DPT at
18 months, and after his DPT at 4 years. All four times the RAD was after a
thimerosal containing shot. He does not have asthma.
Another interesting thing to note is people with asthma are much more likely
to have Glutathione s-transferases M1 and T1 null status. This same risk
factor (null status for GSTM1 and GSTT1) seems to be related to thimerosal
sensitivity, asthma, and neuropsychiatric disorders. As in the thimerosal
studies the asthma study showed that it is very significant to have both
GSTM1 and GSTT1 null status. Null status for both GSTM1 and GSTT1 is
present in 57.9% of the people with asthma and only 4.7% of normal
controls. Low glutathione and null status for GSTT1 and GSTM1 are also
known to occur in inflammatory bowel disease, ulcerative colitis and Crohn's.
I think that GSTT1 and GSTM1 null status might also be very important as a
susceptibility factor in autism, but his dad and brother do.
1.Stroombergen MC, Waring RH.
Determination of glutathione S-transferase mu and theta polymorphisms in
neurological disease.
Hum Exp Toxicol 1999 Mar;18(3):141-5
2. Ivashchenko TE, Sideleva OG, Petrova MA, Gembitskaia TE, Orlov AV,
Baranov VS. Genetika 2001 Jan;37(1):107-11 [Genetic factors in
predisposition to bronchial asthma]. [Article in Russian]
3. Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA,
Strange RC.
Susceptibility to ulcerative colitis and Crohn's disease: interactions
between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta.
1995 Aug 31;240(1):53-61.
4. Harada S, Tachikawa H, Kawanishi Y. Glutathione S-transferase M1 gene
deletion may be associated with susceptibility to certain forms of
schizophrenia. Biochem Biophys Res Commun 2001 Feb 23;281(2):267-71
5. Westphal GA, Schnuch A, Schulz TG, Reich K, Aberer W, Brasch J, Koch P,
Wessbecher R, Szliska C, Bauer A, Hallier E. Homozygous gene deletions of
the glutathione S-transferases M1 and T1 are associated with thimerosal
sensitization. Int Arch Occup Environ Health 2000 Aug;73(6):384-8

http://mercola.com/2003/oct/4/mass_vaccination.htm
By Barbara Loe Fisher
Asthma and Vaccines
Asthma is an autoimmune disorder that tops the list of chronic respiratory
diseases found in children. Although public health officials attribute the
recorded increases in asthma to better case diagnosis, more air pollution
both indoors and outdoors and smoking, some scientists find evidence that
vaccination and lack of contagious infectious diseases in early childhood
may later encourage the development of asthma and other allergic conditions.
In 1996, the British medical journal, The Lancet, published a study that
noted that the incidence of early childhood diseases in Britain had fallen
in the 20th century while those allergic diseases such as asthma, hay fever
and eczema rose sharply. The researchers hypothesized that certain childhood
infections, especially measles, may protect against allergy.
The authors of the 1997 Science article "Asthma: An Epidemic in the Absence
of Infection?" concluded that "childhood infections may, therefore,
paradoxically protect against asthma." And the authors of a study in a 1997
article in Epidemiology concluded that "it is theoretically possible that
immunization may contribute to the development of allergic disease,"
including asthma.
In a 1997 issue of Epidemiology, New Zealand researchers reported that of
1,265 New Zealanders born in 1977, 23 received no childhood vaccinations and
none suffered childhood asthma. Among the 1,242 who got DPT and polio shots,
23 percent later had episodes of asthma, 23 percent had asthma consultations
and 30 percent had consultations for other allergic illness.
In a 2000 study, researchers, in reviewing data from the National Center for
Health Statistics from 1988 to 1994 and comparing vaccinated to unvaccinated
children, found that a child who received DPT or tetanus vaccination was 50
percent more likely to experience severe allergic reactions, more than 80
percent more likely to experience sinusitis and twice as likely to
experience asthma as those children who were not vaccinated. The authors
concluded that "asthma and other allergic hypersensitivity reactions and
related symptoms may be caused, in part, by the delayed effects of DPT or
tetanus vaccination."
Autism and Vaccines
The dramatic rise in the numbers of cases of autism in the past few decades,
particularly since the early 1980s, has been increasingly linked to
vaccination in recent years, as it has become more evident that autism has a
biological and not a psychological basis. The medical literature identified
only a handful of autism cases in the 1940s. After the DPT vaccine became
widely used in the 1950s and the new live virus measles vaccine was in
routine use after 1965, the numbers of autistic children began to grow.
By 1979, the combination live-virus MMR vaccine was added to the routine
child vaccination schedule and given to children at 12 to 15 months of age
while federal grants were given to states to provide free DPT, live oral
polio and MMR vaccines to children in public health clinics. In California,
where cases of autism have been monitored since 1970, there was a steep and
steady rise in the numbers of autism cases beginning in the early 1980s.
The old theory that children were made autistic because their mothers were
"cold" and did not provide enough nurturing was discredited in 1964 by the
pioneering autism researcher, Bernard Rimland, Ph.D. The fact that autism
appears to be a biological disorder has only slowly gained acceptance with
the recognition that autistic children are suffering a wide range of immune
and brain system dysfunction. In addition to classic autistic behaviors such
as spinning, rocking, flapping, lack of eye contact and speech, many
autistic children today have gastrointestinal disorders, seizures, learning
disabilities and severe allergies.
The connection between vaccination and autism was first reported 18 years
ago in DPT: A Shot in the Dark (which I co-authored with Harris Coulter),
but today the subject of autism and vaccines has become the most
controversial vaccine safety topic debated in the pages of medical journals,
on broadcasts and in print journalism reports, in congressional hearings and
in homes of parents of autistic children.
DPT vaccine-induced autism is thought to follow post-vaccine brain
inflammation that one 1981 British study (the National Childhood
Encephalopathy Study) estimated occurs after 1 in 110,000 DPT shots. In the
U.S. several awards for DPT vaccine-induced autism have been made in the
federal Vaccine Injury Compensation Program (VICP).
However, most of the arguments about the causal relationship between
vaccines and autism have focused on the live MMR vaccine as well as on
inactivated vaccines that have contained a mercury preservative, thimerosal.
In 1998, an unsuspecting young British gastroenterologist suddenly found
himself in the midst of a hurricane for discovering a possible connection
between the MMR vaccine and autism. Andrew Wakefield, M.D. and 13 colleagues
published a report in the February 27, 1998 issue of The Lancet about a new
syndrome involving inflammatory bowel disease and autism in children. Eight
out of 12 normal children who developed severe intestinal disorders soon
after an MMR vaccination also became autistic. Previously five of those
eight children had reacted adversely to vaccinations.
The team of British scientists, who had inadvertently stumbled upon the
connection while studying Crohn’s disease and other inflammatory bowel
dysfunction in children, emphasized that they had not proved a cause and
effect relationship. They called for more studies to investigate whether
persistent viral infection, either from natural disease or live virus
vaccines, can lead to central nervous system damage in some children that
takes the form of autism.
Nevertheless, in the same issue of The Lancet, CDC officials Robert Chen, MD
and Frank DeStefano, MD charged in an editorial that, "vaccine safety
concerns such as that reported by Wakefield and colleagues may snowball"
when the public and the media "confuse association with causality and shun
immunization." Other CDC officials discounted the study’s importance, saying
the children’s health problems were "coincidental" and not caused by
vaccination.
Soon after, a Reuter’s newswire story quoted Johns Hopkins Neal Halsey
saying it was "highly inappropriate" for Wakefield and his colleagues to
discuss a possible connection between the children’s health problems and
measles or MMR vaccines. Wakefield was called before the Medical Research
Council in the U.K. where British, U.S. and WHO health officials criticized
his report for unnecessarily frightening the public.
Undeterred, Wakefield subsequently published a study providing evidence for
the presence of measles virus in the intestines of children suffering from
autism and intestinal bowel disorders, while not finding evidence for
measles virus in normal, healthy children. He continued to maintain that
children with a pre-existing immune abnormality may be predisposed to
sequestering the measles virus in the gut and that the MMR vaccine prompts
them to develop autoimmunity leading to immune mediated CNS damage.
In 2001, the IOM Immunization Safety Review Committee examined the Wakefield
hypothesis and concluded that "the evidence favors rejection of the causal
relationship at the population level between MMR and vaccine and autistic
spectrum disorders," but the committee also stated that "the proposed
biological models linking MMR vaccination to autism spectrum disorders,
although far from established, are nevertheless not disproved." The
committee called for further scientific research into the occurrence of
autism in children following MMR vaccination.
In 2003, Utah State University researcher Vijendra Singh published a
serologic study in Pediatric Neurology reporting that measles antibody was
significantly higher in autistic children compared with normal children and
the antibody was directed against a protein. He hypothesized that autistic
children have a hyperimmune response to measles virus which, in the absence
of wild type measles infection, might be a sign of an abnormal immune
reaction to measles vaccine strain virus or virus reactivation.
Shortly after Wakefield and his colleagues published initial evidence for an
association between MMR vaccine and autism, in 1999 the U.S. Food and Drug
Administration (FDA) and the Environmental Protection Agency (EPA) directed
vaccine manufacturers to remove the mercury preservative, thimerosal, from
childhood vaccines. EPA and FDA officials issued their directive in response
to federal legislation requiring the evaluation of products containing
toxins, such as mercury.
An analysis of mercury levels in childhood vaccines found that the total
amount of mercury children were exposed to in routinely given vaccines (DPT,
DTaP, Hib, hepatitis B) exceeded EPA toxic exposure guidelines. Mercury is a
known neurotoxin, which can cross the placenta and blood brain barrier and
concentrate in the blood and brain but can also affect the immune system,
kidneys and lungs. A pregnant woman’s exposure to high levels of mercury has
been shown to cause brain damage in the fetus.
There was special concern about mercury in childhood vaccines because, as of
1991, the CDC and American Academy of Pediatrics (AAP) had recommended that
all newborn babies receive their first hepatitis B vaccine at 12 hours of
age and again at one month of age. Hepatitis B vaccine, along with DPT, DTaP
and Hib vaccines given at two months, four months and six months of age all
contained mercury.
By the end of 2001, all but trace amounts of thimerosal had been removed
from DPT, DTaP, Hib and hepatitis B vaccines as manufacturers moved to
package these vaccines in single dose vials that did not require a
preservative (thimerosal is still present in DT and inactivated flu vaccine
as well as certain combination DTaP-Hib and hepatitis B vaccines).
During the past four years, many parents with autistic children have become
convinced that their children are mercury poisoned including those parents
who founded SAFEMINDS. Scientists such as Boyd Haley, Chairman, Department
of Chemistry, University of Kentucky, have given expert testimony in support
of those concerns during investigative hearings held by Congressman Dan
Burton (R-IN) in the U.S. House Government Reform Committee.
In 2001, the IOM Immunization Safety Review Committee issued a report that
found the hypothesis that exposure to thimerosal-containing vaccines "is not
established" but is "biologically plausible," and concluded that the
evidence is inadequate to accept or reject a causal relationship between
exposure to thimerosal from vaccines and the neurodevelopmental disorders of
autism, ADHD and speech and language delay." The report called for removal
of thimerosal from childhood vaccines and replacement of existing stocks of
thimerosal containing vaccines with mercury-free vaccines.
An attempt by the vaccine industry to insert a rider in the Homeland
Security Bill in late 2002, which would have protected vaccine manufacturers
from lawsuits for harm caused by toxic additives and components of vaccines,
such as thimerosal, further convinced parents that thimerosal is a cause of
autism. The rider was eventually removed from the legislation, but parents
of autistic children continue to be frustrated in their efforts to obtain
recognition of thimerosal-induced autism as they seek compensation in the
tort system and in the federal vaccine injury compensation program (VICP)
for their children.
Evidence has been accumulating that suggests some children may not be able
to excrete mercury from the body as efficiently as other children. In 2003,
one study reported that urinary mercury concentrations were significantly
higher in children with autistic spectrum disorders than in normal controls.
The authors concluded that "data from this study, along with emerging
epidemiologic data showing a link between increasing mercury doses from
childhood vaccines and childhood neurodevelopment disorders, increases the
likelihood that mercury is one of the main factors leading to the large
increases in the rate of autism and other neurodevelopment disorders."
Autoimmunity Family History and Autism
The significance of a family history of autoimmunity and autism was
highlighted in a 1999 study published in the Journal of Child Neurology,
which found a statistically significant correlation between a family history
of autoimmune disorders and autism.
When comparing the medical histories of families of 61 autistic patients and
46 healthy controls, the authors discovered "that the subjects who reported
two or more family members with autoimmune disorders were twice as likely to
have autism, those with at least three family members with autoimmune
disorders were 5.5 times more likely to have autism, and those whose mothers
had autoimmune disorders were 8.8 times more likely to be affected."
The researchers added "the percentage of family members with adult
rheumatoid arthritis, systemic lupus and the category of connective tissue
autoimmune disorders were greater in the autism group than in controls and
approached statistical significance in these cases." They suggested that
perhaps "individuals with autism inherit a genetic predisposition for
autoimmunity that, in conjunction with medical triggers or other
environmental factors, results in developmental and neurologic pathology."
Vaccines and the Law
If adverse responses to vaccination are under genetic control, then laws
requiring vaccination are a de facto state-enforced selection and sacrifice
of the genetically susceptible. Yet, refusal to vaccinate one’s children
with every mandated vaccine in the U.S. can result in denial of an
education, including enrollment in day care, elementary school, high school,
college, and graduate school; denial of health insurance; denial of
employment; and threatened denial of government benefits for poor children,
including food and medical care.
In addition, parents who don’t comply with vaccination laws have been
charged with child medical neglect and threatened with having their children
taken from them. Parents of children, even acutely ill children, are being
thrown out of pediatrician’s offices in Texas and other states if the
parents attempt to make independent vaccine choices for their children.
All 50 states provide a medical exemption to vaccination laws that doctors
licensed to prescribe drugs can write. All but two states (West Virginia and
Mississippi) allow exemptions for religious beliefs, but some states require
that parents belong to a religion that has a written tenet opposing
vaccination, although several state Supreme Courts have found this
requirement unconstitutional. Some 18 states provide for philosophical,
personal belief or conscientious belief exemption, but less than 1 percent
of all children in the US are exempted from vaccination for any reason.
Although American vaccine laws fall under state, rather than federal,
jurisdiction, as soon as the CDC recommends a new vaccine for "universal
use" in children, state health officials automatically make it mandatory.
So, while state health officials only required children to show proof of one
smallpox vaccination to enter school in 1949, by 2003 most states required
children to be injected with 34 doses of 10 vaccines.
Tracking Vaccines to enforce compliance
To encourage high vaccination rates, federal health officials give grants
and other financial incentives to state health and education agencies, or
withhold them. In 1993, Congress authorized more than $400 million for
states that enforced mandatory vaccination by using social security numbers
to track children from birth. Simultaneously, a grant program rewards state
health departments with up to $100 for each fully vaccinated child.
The government eventually plans to link state vaccine tracking systems
together to create a government operated electronic database monitoring
everyone’s medical records, including vaccination status, from birth. (One
federal proposal would link a national ID "smartcard" to a driver’s license
and health care or a job.) Individual legislators at both the state and
federal levels have already proposed tax penalties for citizens who don’t
fully vaccinate their children.
A number of private companies and organizations are already working with
governments around the world to ensure "the integration and harmonization of
immunization registries" through the promotion, standardization, and
acceptance of computerized patient records systems that would monitor the
health status of every child.
The Children’s Vaccine Initiative (CVI) launched in 1990 at the World Summit
for Children in New York City, set a goal to develop global strategies for
"the development and utilization" of vaccines by all the world’s children.
CVI received money from the United Nation’s Children’s Fund, the United
Nations Development Program, the World Bank, WHO and the Rockefeller
Foundation and major vaccine manufacturers.
In 1994, CDC health officials developed the National Vaccine Plan for the
U.S., which "provides a framework in which diverse domestic and
international, public and private sector activities in immunization and
vaccine development can be effectively coordinated."
HIV and Sexually Transmitted Disease Vaccines for Children
In a February 12, 1997 meeting of the CDC’s Advisory Committee on
Immunization Practices, committee member Neal Halsey reminded HIV vaccine
researchers that the government plans to target preteens for universal
application of an HIV vaccine.
Halsey told them "one of the things that’s happened in the past with
vaccines is that sometimes the manufacturers have developed them and tested
them primarily in an age group or a population which may not be the final
target population that this committee has considered … We really see age 11
to 12 as the target for introduction of vaccines for prevention of sexually
transmitted diseases … It would be nice if there were studies that were
planned in parallel when you move another step in the direction of actually
having a candidate [HIV] vaccine, realizing where we think we would want to
use universal application of such a [HIV] vaccine."
But there are other plans to target adolescents for vaccines being developed
for genital herpes, papillomaviruses that cause genital warts, and
cytomegalovirus, all which are sexually transmitted. A spokesperson for the
National Institute of Allergy and Infectious Diseases, which is sponsoring
clinical trials of a herpes vaccine, was quoted as saying "Parents will have
to take their daughters in to the pediatricians when they’re little girls to
get them protected against sexually transmitted disease."
Vaccines for sexually transmitted diseases are not the only vaccines that
will target adolescents. In 2003, researchers announced development of
anti-smoking and anti-cocaine use vaccines but admitted there might be some
resistance by parents to accepting these lifestyle vaccines for their
children.
Getting Vaccinated in America to Vaccinate the World
As public health officials increasingly define disease control in global,
rather than national, terms, mass vaccination proponents and vaccine makers
must find ways to finance delivery of newer and more expensive vaccines to
poor countries.
They accomplish this by first making the vaccinations mandatory in rich
countries, as HIV vaccine developer Stanley Plotkin, M.D., of Pasteur
Merieux Connaught, explained in 1996: "The keystone of the [global mass
vaccination] system is that the research costs [of drug companies] are
recouped in North America and Europe, and the vaccines are sold in the
developing world at much, much lower margins…The relatively high rate of
childhood vaccination seen lately in most parts of the world is the result
of that system."
In 1998, the CDC illustrated how this funding formula works by recommending
that all American babies under six months receive three doses of rotavirus
vaccine for diarrhea. Although a serious health problem in the Third World,
where more than 800,000 babies lacking adequate nutrition or health care die
from dehydration caused by severe diarrhea every year, most American babies
recover from bouts with rotavirus and are left with permanent immunity.
About 20 to 40 babies die of rotavirus infection in the US every year.
By the summer of 1999, the rotavirus vaccine was pulled off the US market
after it was discovered that babies were being injured and dying from bowel
blockages following rotavirus vaccination.
Vaccine production problems and new epidemics
The rotavirus vaccine, which cost $40 a shot, was the first rhesus-human
reassortment vaccine, created by co-cultivating rhesus monkey rotavirus
strains with human rotavirus strains to create a genetic human-monkey hybrid
strain of rotavirus. This production process, while more sophisticated,
recalls the use of rhesus monkeys to produce the original Salk polio
vaccine.
In the rush to put a polio vaccine on the market in 1955, polio vaccine
pioneer Jonas Salk unknowingly used rhesus monkey kidney tissues
contaminated with monkey viruses. By 1960, an NIH scientist, Bernice Eddy,
discovered that rhesus monkey kidney cells used to make the Salk polio
vaccine and experimental oral polio vaccines could cause cancer when
injected into lab animals. Later that year the cancer-causing virus in the
rhesus monkey kidney cells was identified as SV40 or simian virus 40, the
40th monkey virus to be discovered.
Unfortunately, the American people were not told the truth about this in
1960. The SV40 contaminated stocks of Salk polio vaccine were never
withdrawn from the market but continued to be given to American children
until early 1963 with full knowledge of federal health agencies.
Between 1955 and early 1963, nearly 100 million American children had been
given polio vaccines contaminated with the monkey virus, SV40.. Today, US
health officials admit that the Salk polio vaccine was contaminated with
SV40 and that SV40 has been proven to cause cancer in animals. At a
conference on SV40 and human cancers held by the National Institutes of
Health in 1997, there was no disagreement among both government and
non-government scientists about these two facts.
The only disagreement was whether SV40 was actually being identified in the
cancerous tumors of children and adults alive today and, if it was, whether
the monkey virus was in fact responsible for their cancer. Non-government
scientists working in independent labs around the world said, yes." But the
scientists connected with the US government said "no."
Highly credentialed non-government scientists continue to identify SV40 in
human brain and lung cancers and are finding that SV40 is also associated
with bone cancers and Non-Hodgkins Lymphomas. And in a report published in
2001 on SV40 and cancer, the Institute of Medicine stated that "in light of
the biological evidence supporting the theory that SV40 contamination of
polio vaccines could contribute to human cancers, the committee recommends
continued health attention in the form of policy analysis, communication and
targeted biological research."
At a September 10, 2003 investigative hearing of the U.S. House Subcommittee
on Human Rights and Wellness chaired by Congressman Dan Burton, testimony
was provided by attorney Stanley Kops that the Salk vaccine was not likely
the only vaccine contaminated with SV40 and used by millions of American
children.
Since 1963, the vaccine manufacturer and federal health agencies have
assured the world that, while the Salk vaccine was made using the SV40
infected rhesus monkey kidney tissues, the oral polio vaccine used after
1963 was made using African Green monkeys, which are rarely infected with
SV40. The vaccine manufacturer and government health officials have insisted
that the switch from rhesus monkey to African Green, as well as testing
protocols to detect SV40, prevented SV40 from contaminating oral polio
vaccine after 1963.
At the hearing, Kops presented internal vaccine company memos and federal
agency documents suggesting that (1) the original seed stocks of oral polio
vaccine were made using the rhesus monkey and were contaminated with SV40;
(2) the major oral polio vaccine manufacturer did not adequately test their
master seed stocks which reportedly contained SV40 but used them to produce
vaccine released for use by American children from the 1960’s through the
1990’s; and (3) federal regulatory agencies either did not know or knew and
did not do anything about evidence that SV40 contaminated oral polio vaccine
was released for use by the public from the 1960s through the 1990s.
If SV40-contaminated rhesus monkeys were used to produce original OPV seed
stocks, and if these seed stocks were used to produce oral polio vaccine
that was swallowed by American children through the 1990’s, and if SV40 does
cause human brain, lung and bone cancers, then this could explain why
children today, who were not born before 1963 and never got the SV40
contaminated Salk vaccines, are now sick and dying from cancerous tumors
containing DNA from a monkey virus that was in those vaccines.
Pediatric brain cancer, once rare, rose during the past few decades
according to the National Cancer Institute. But it is unknown how many of
these children had or have SV40 in their brain tumors because nobody checks.
The precedent that has been set by federal health agencies allowing SV40 to
contaminate polio vaccine given to millions of children may be influencing
how new vaccines are being created. Transcripts of meetings in 1998, 2000
and 2001 of the FDA Vaccines and Related Biological Products Advisory
Committee which dealt with adventitious agent contamination of vaccines,
reveals that vaccine manufacturers are asking the FDA for permission to use
cells from human and animal cancer tumors--cancer cells--to make HIV and
other viral vaccines in the future that would be used on a mass basis.
There has been a federal ban on the use of cancer cells to produce vaccines
since 1954 but active consideration is being given to lifting that ban
despite the acknowledged risks of contamination with adventitious agents,
including residual DNA and RNA.
There is frank admission that the limitations of technology and lack of
scientific knowledge means there can be no guarantee that vaccine will not
be contaminated with substances that could prove harmful to humans one day.
Nevertheless, there are plans to set allowable threshholds for adventitious
agent contamination of vaccines.
A Brave New World
In 1997, CDC official Walter Orenstein, M.D., testifying before the US
Congress, painted a picture of the future in his annual appeal for more
vaccine funding. "On the horizon are vaccine technologies that would have
been considered science fiction just a decade ago but are now reported at
scientific meetings," he said. "Snippets of synthetic DNA have worked as
experimental vaccines in animals. Edible plants have been bioengineered to
become vaccine factories…Vaccines have been enclosed in microscopic
capsules, permitting them to be released slowly over time."
Several years ago, vaccine researchers held a press conference in
Washington, D.C. to announce research to create a genetically engineered "supervaccine"
that will be given orally at birth. This supervaccine--dubbed by one
researcher as the "Holy Grail"--will contain raw DNA from 20 to 30 viruses,
parasites, and bacteria that will be inserted directly into the cells of
babies.
The vaccine will be time-released over several months. Disease organisms
scheduled to be included in the supervaccine are pneumonia (three viruses),
AIDS (two viruses); dengue hemorrhagic fever (four viruses), diarrheal
disease (several viruses and bacteria), measles, meningitis (six viruses and
bacteria), polio (three viruses), schistosomiasis (one parasite),
tuberculosis, typhoid fever and pertussis.
In all, vaccine manufacturers and US govermment researchers are developing
more than 150 different viral and bacterial vaccines. A live virus flu
vaccine that will be squirted up the nose has been licensed and will target
all healthy children and adults between the ages of 5 and 49 in the coming
flu season.
Adhesive skin patch vaccines and high technology jet guns will someday
deliver vaccines designed to prevent strep throat, asthma, stomach ulcers,
tooth decay, cancer and the common cold. If the microbe fighters have their
way, the "Brave New World" of the future will truly be infection free.
Or will it? In 1993, scientists at the American Society of Microbiology
annual meeting reported that diseases such as tuberculosis and meningitis
have become resistant to antibiotics because of their overuse in the past
decades. One study shows that pediatricians are prescribing antibiotics for
44 percent of children with common colds. In 1998, evidence of
penicillin-resistant strep bacteria caused worry that more people will die
from severe pneumonia, bacteremia and meningitis.
That same year a government report warned that the overuse of antibiotics in
animals, which transfer microbes from livestock to humans through the food
chain, is producing resistant bacteria, including antibiotic resistant
salmonella, enterococci and E. coli. Health officials warn food producers
that antibiotics should never substitute for "inadequate hygiene."
Now there are signs that viruses and bacteria, eager to survive, may be
outsmarting vaccines. A 1998 study published in the British Medical Journal
found that B. pertussis infection is occurring in vaccinated populations in
the Netherlands, Norway and Denmark despite vaccination rates as high as 96
percent. Among other causes of the whooping cough outbreaks, scientists have
found an increasing incidence of B. pertussis with a mutated surface
protein.
In 1998, a CDC study identified eight distinct genotypes of a wild-type
measles virus in populations around the world. In January of 1999, the CDC
reported a 1998 measles outbreak in Alaska in which 51 percent of the
children had received one or more doses of measles vaccine. Will health
officials add yet another dose of measles vaccine, as they did during
measles outbreaks in the late 1980s when they realized that one dose failed
to do the job?
While the global village gets smaller and smaller, U.S. health officials
warn parents and the media that terrible diseases killing children in the
Third World are "just a plane ride away." The climate of fear that has been
created post September 11, 2001, saw government health officials attempt to
convince the American public that the most reactive vaccine ever used by
humans--the live virus smallpox vaccine--should again be used by everyone to
prepare for the possibility of a smallpox bioterrorist attack. Ironically,
it was the American health care workers, who give vaccines, who took a look
at smallpox vaccine risks and said "No thanks" to that plan.
The microbe hunters, who want us all to believe as they do that vaccines are
the weapons we must all use to insure the health and well being of mankind,
are so far winning the political battle for the hearts and minds of the most
influential segments of our society. And yet, the parents and doctors
questioning their wisdom and their authority are making their pleas for
thoughtful reconsideration of the global mass vaccination plan heard in many
forums.
"What we forget is that millions of years of evolution have taken place on
this planet, and up until the last 100 years, humans have lived in relative
harmony with microbes. Yes, there have been epidemic infectious diseases in
history, but they have always resolved themselves," said Richard Moscowitz,
M.D. "I don’t think there is any real appreciation for what we may be doing
by using so many vaccines to try to eradicate so many organisms."
If we stay the present course, will mankind be free from infectious disease
but crippled by chronic disease? Will eradication of feared diseases, such
as AIDS, through mass vaccination be one of man’s greatest triumphs or will
we live in fear of deadly mutations of microbes that have outsmarted man’s
attempt to eradicate them? We may look back at the crossroads we are at
today and wish we had decided to make peace with nature instead of trying to
dominate it.
Whatever government and industry decide to do, public support for mass
vaccination programs will continue to erode if public policy continues to
precede science and individual health is dismissed as less important than
public health. Doctors, who enforce vaccination without allowing informed
consent and insist that some may be sacrificed for the greater good, will
continue to lose the faith and trust of the people. Vaccines will come to be
associated with feelings of fear and harm instead of feelings of safety and
protection as the vaccine safety debate becomes more polarized and citizens
calling for forced vaccination are pitted against those calling for freedom
of choice.
Perhaps the peace we need to make is not as much with nature, as with
ourselves.

http://www.reutershealth.com/archive/2004/03/24/eline/links/20040324elin015.
html
Flu vaccine may be linked with asthma in infants
Last Updated: 2004-03-24 16:19:03 -0400 (Reuters Health)
By David Douglas
NEW YORK (Reuters Health) - A study of more than 9,000 children and
adolescents indicates that the use of the nasal influenza vaccine (FluMist)
is generally safe. However, questions still remain about the risk of
reactive airway disease in certain children under the age of 3 years.
As researcher Dr. Steve Black told Reuters Health, "there was a
suggestion that (such) children vaccinated with (FluMist) were at
increased risk for medical visits for asthma within 6 weeks following
vaccine as compared to controls. However, children with asthma prior to
vaccination, overall, had a lower risk of asthma visits as compared to
controls."
In the Pediatric Infectious Disease Journal, Black of the Kaiser
Permanente Vaccine Study Center in Oakland, California, and colleagues
note that they came to these conclusions after a trial of the nasal flu
vaccine in children between 1 and 17 years old. All received at least one
dose of vaccine or placebo. Those 8 years or younger received a second
dose 28 to 42 days later. All children were followed for 42 days after
each vaccination.
Following evaluation of 9,689 children, there appeared to be no
association between vaccination and acute respiratory tract infections,
systemic bacterial infection, acute GI complaints, and those potentially
associated with influenza. However, in children aged 18 to 35 months
there was a four-fold increased risk of reactive airway disease.
Thus, continued Dr. Black, "our conclusion was that the risk of asthma
following (nasal flu vaccination) in children less than three years old
needed further evaluation prior to the use of the vaccine in that age
group." They theorize that if this increased risk is confirmed in another
study, it
may be that these children have never been exposed to an influenza virus
"and might respond to this vaccine differently because of this."
SOURCE: Pediatric Infectious Disease Journal, February 2004.

http://poisonevercure.150m.com/asthma.htm
Flu Vaccine May Lead to Asthma in Infants
Reuters March 24, 2004
Although studies have indicated the safety of the use of FluMist,
nasal influenza vaccine for children and adolescents, questions regarding
the risk of reactive airway disease among children under the age of three
still exists.
Research suggested that certain children who received the FluMist
vaccine had an increased risk for medical asthma-related visits within
six weeks after the vaccine was administered as compared to controls.
However, it was found that children who already had asthma before they
received the vaccination, on the whole, had decreased their risk of
asthma compared to the control group.
Experts noted that these findings were the result of conclusions
following a trial of the nasal flu vaccine in children that fell in the
1- to 17-year-old age groups. In these studies, the children received at
least one dose of vaccine or placebo and the children 8 years or younger
were given a second dose 28 to 42 days later.
Based on the evaluation of 9,689 children, there appeared to be no
definitive link between the vaccination and acute respiratory tract
infections, systemic bacterial infections, acute GI complaints and others
possibly associated with the flu. There was a four-fold increased risk of
reactive airway disease among children aged 18 to 35 months.
It was concluded that if this increased risk of reactive airway
disease was confirmed in another study, it would be a possibility the
children had never been exposed to a flu virus and might react
differently to the vaccine.

http://my.webmd.com/content/article/86/99060.htm?lastselectedguid=%7B5FE84E90-BC77-4056-A91C-9531713CA348%7D
Autism Linked With Immune System
Children With Autism Have More Digestive, Food Allergies
By Jeanie Lerche Davis
WebMD Medical News Reviewed By Brunilda Nazario, MD
on Monday, May 03, 2004
May 3, 2004 -- Autism may be linked with immune system abnormalities.
Researchers have uncovered a pattern of allergies among children with
autism, especially food and digestive allergies.
Lead researcher Thomas Webb, MD, with Cincinnati Children's Hospital
Medical Center, presented his report this week at the Pediatric Academic
Societies annual meeting in San Francisco.
Autism is a complex disability that interferes with a person's ability to
interact with others. Signs of autism are usually evident by age 3.
Doctors have long believed that autism is caused by irregularities in
brain function that affect the development of communication and social
skills.
In his study, Webb analyzed Census Bureau data from 1997 to 2001 for
about 55,000 households, identifying 152 children with autism. He found
that children with autism were almost three times more likely to have a
reported history of a digestive or food allergy than other, healthy
children. They also had slightly more respiratory and skin allergies, but
they were less likely to have a reported history of asthma.
Among children in the general population, asthma rates are higher than
digestive and food allergies, Webb notes. Some research has shown that
among children with autism, the immune cell receptors seem to be
different, he writes. These receptors respond to allergy triggers, like
pollen or certain food chemicals. The findings warrant further research
of this link between autism and allergic diseases, he writes.

Subject: Asthma Rates Soaring
Asthma Rates Soaring
From 1970 until 2004, American cheese consumption went from 11 pounds per
person per year to 31 pounds. During that same time period, consumption
of cheese in New Zealand went from 3 pounds to 24 pounds per person per
year, an increase of eight times. For dairy lovers, New Zealand's grazing
cows enjoy a reputation made possible by perfect climate and enormous
open space, making New Zealand the fifth largest cheese exporter in the
world, behind France, the Netherlands, Germany and Denmark.
As New Zealand's cheese consumption increased over time, so too did their
asthma rates. Nobody in New Zealand seems to have made the connection. At
the end of this column is an article that appeared in this week's (May 4,
2004) New Zealand Herald newspaper. The New Zealand Herald reporter was
equally as clueless as a New York Times reporter who wrote a similar
story about Asthma in the United States on April 19, 2003. Shortly after
that article appeared,
I wrote:
One Out of Four Harlem Kids Has Asthma
"Many cases of asthma and sinus infections are reported to be relieved
and even eliminated by cutting out dairy."
Frank Oski, M.D., Chief of Pediatrics at Johns Hopkins
Medical School Natural Health, July, 1994
_______________________________________________________
Saturday's Page One New York Times story (4/19/03) confirmed everything
I've been writing since 1995. One out of four children in Harlem tests
positive for asthma.
Scientists were shocked by the latest data. According to the New York
Times, that frequency of asthma is more than double the incidence rate
which researchers expected to find. America's national average asthma
rate runs about six percent, or nearly one out of seventeen. Scientists
tested 2000 children under the age of 13 living in one 24-block New York
City Harlem neighborhood and found that 25.5% of the kids had asthma. The
researchers are clueless as to the cause, but have observed that the
asthma rate has doubled since 1980. Geoffrey Canada, president of
the Harlem Children's Zone, the study's sponsor, said:
"This is a very poor community where a lot of the families have very
troubled lives, with lots of stresses..." For many children, living in
Harlem means living below the poverty level. USDA runs an anti-nutrition
program called WIC (Women/Infants/Children). The foundation of WIC's food
giveaway program is subsidized milk and dairy products, purchased at
retail to bail out failing dairy farmers who have no other outlet for
their surplus product. Our government also feeds 28 million school
kids each day with their National School Lunch Program and School
Breakfast Program (SBP). Those milk meal giveaways cost over 6 billion
dollars per year, which does not include the cost of medical
treatment for asthma attacks and asthma medicine.
In attempting to explain exploding asthma rates, the New York Times
article reports:
"Some of the worst triggers, studies have found, are most prevalent in
poor communities, including the feces of cockroaches and dust mites,
cigarette smoke and mold and mildew. Harlem, East Harlem and the
South Bronx also have a heavy concentration of diesel bus and truck
traffic, and the
tiny particles in diesel exhaust are though t to be another serious
asthma trigger." Environmental considerations are all very important, of
course, and everybody wants more than one breath of fresh
air each day, but not one of the factors cited by the Times has doubled
since 1980. One factor, though, not considered by researchers, has more
than tripled. In 1980, the average American was eating just ten pounds of
cheese per year. Today, the average American consumes thirty-one pounds
of cheese.
Eighty percent of milk and cheese protein is casein. When casein is
isolated from milk, it becomes the glue to adhere a label to a bottle of
beer. Casein is the glue used to hold together wood in furniture. When a
child living in Harlem eats cheese or ice cream, this allergy-causing
milk protein
triggers the production of histamines, which in turn create mucus.
Sometimes, the reaction takes as long as 12 hours. Tonight's slice of
pizza may trigger tomorrow's asthma attack.
Asthma is not the only result. Milk hormones interfere with a child's
ability to learn. It is a wonder that only one out of four kids living in
poverty have asthma. Perhaps the other three are fortunate enough to be
severely lactose intolerant, and avoid complimentary bovine secretions
like the plague.
Ninety-five percent of African-Americans cannot tolerate lactose. Pizza
and ice cream taste delicious on the way into their bodies. Lactose is a
sugar and most people need the enzyme lactase to break down lactose into
glucose and galactose. Intact, this sugar is broken down in the
intestines by bacteria and the results are gas, bloating, and intestinal
distress.
Milk contains powerful hormones. Rates of sexual maturity in children are
astounding endocrinologists and behavioral psychologists. A recent study
revealed that eighty percent of nine-year-old African-American girls have
developing breasts. Children are becoming overweight at an early age. By
eating high caloric food with growth hormones and saturated animal fat,
the body has a way of listening to the signals of those chemical
messengers: Grow!
One out of five children has Attention Deficit Disorder (ADD).
A recent study in the Journal of Autism linked ADD with a milk protein,
casomorphin.
Herman Mitchell, an asthma researcher and epidemiologist, has this
comment regarding the shocking Harlem asthma data:
"This is certainly one of the highest rates attributed in the United
States, if not the highest."
With that inspiring comment, I decided to take advantage of a lull in New
York City's perpetual traffic jam. Easter Sunday afforded such an
opportunity. It would not be practical for me to enter the schools and
follow 2000 kids, but I could perform my own completely unbiased
observation of Harlem. I drove from my New Jersey home to the 125th exit
off of the West Side Highway, and soon found myself in "the hood."
Our New Jersey neighborhood has one pizzeria, and we once had an ice
cream store, but it closed for lack of business in January of this year.
We have cigarette smokers, mice, and insects, but there is no WIC service
in our school systems. Little or no poverty can be found in Oradell, New
Jersey. No subsidized daily dairy overdoses for our children.
Dairy is a major part of Harlem's in-school food culture. That same bad
habit has become an addiction of the streets. The study area was bounded
by 116th Street, 123rd Street, Fifth Avenue and Eighth Avenue. There were
just too many dairy outlets to count. I took notes as I drove, and gave
up on 116th Street. I found Domino's Pizza, and Baskin Robbins Ice Cream.
Krispy Kreme Donuts and fast food franchises serving shakes and
cheeseburgers. As I drove through the streets, I observed hundreds upon
hundreds of quick-fix dairy foods providing after school treats.
The poorest children in America begin their day at schools with milk and
cereal for breakfast. Snack time provides chocolate milk and cookies.
Lunch means macaroni and cheese or pizza. The casein within the
mozzarella cheese and cheddar insures poor digestion, and sets into
motion a reaction by which the bronchioles of a child's lungs clog with
mucus.
Here is what happened to one very famous American who lived and died by
the milk mustache. Flo Jo choked on her body fluids, dying from an asthma
attack. Her autopsy:
http://notmilk.com/deb/flojoms.html
As promised, the article in yesterday's New Zealand paper:
_________________________________________________________________
NEW ZEALAND HERALD
Tuesday, May 4, 2004
Asthma rate triple world average
By MARTIN JOHNSTON, health reporter
New Zealanders suffer asthma at three times the global rate, according to
the first international assessment of the disease. The New Zealand-led
assessment, which combines previous studies, estimates that 300 million
people, about 5 per cent of the global population, suffer asthma.
The rate among New Zealanders is 15 per cent.
The prevalence of the disease is rising - particularly where populations
are urbanising and adopting Western lifestyles - but the basic reasons
remain unclear. The latest study, for the World Health Organisation and
the Global Initiative for Asthma, is published today to coincide with
World Asthma Day. It predicts that by 2025, some 400 million to 450
million people will have asthma, an increase of up to 50 per cent. The
lead researcher, Professor Richard Beasley, director of the
Wellington-based Medical Research Institute, said last night that the
study provided the first firm estimate of the disease's global prevalence
using standardised data.
He said the rising prevalence was driven by a growing population, people
shifting from rural areas to cities and the spread of Western habits. "We
know that with the adoption of urban and Western lifestylesthe rate of
asthma goes up markedly.
"One of the strong factors from studies, particularly in developing
countries, is that asthma prevalence rates are much higher in cities than
in rural areas. The exact features of the lifestyle associated with
urban living have not been identified with certainty in terms of why
their rates are so much higher." The research report says that when
people from Southeast Asia and the Pacific Islands emigrate to Australia
and New Zealand there is a marked increase in asthma prevalence within
one generation.
Many scientists are investigating the "hygiene hypothesis" - that
increasingly sanitised living conditions and a decreasing exposure to
bugs early in life primes the immune system to overreact later, producing
allergic diseases. Most asthma is triggered by allergies. Professor
Beasley said this theory explained part of the rise in asthma, "but it's
not the whole answer". Despite New Zealand's high asthma prevalence, the
rate of people dying from the disease is within the range of many
Western countries at 4.6 per 100,000 asthmatics. At the Western
extremes, Canada's rate is 1.6 and Denmark's 9.3. The world's worst rate
is in China, at 36.7.
"New Zealand used to have far a higher mortality and case-fatality rate,"
Professor Beasley said. They had fallen steeply in the past 10 years
because of the withdrawal of the drug fenoterol, which was dangerous when
overused, the greater use of inhaled corticosteroids and the use of
asthma management plans.
ASTHMA BURDEN
Global prevalence of asthma estimated to be 300 million people or about 5
per cent of the population.
New Zealand prevalence 15 per cent.
225,723 people died from the disease worldwide in 2001.
Asthma is 300 times more common than coronary heart disease.
The global economic costs of asthma exceed those of TB and HIV/Aids
combined.

http://www.smh.com.au/articles/2004/07/23/1090464867466.html?oneclick=true#
Flu shots linked to asthma attacks
By Michael Bradley
July 24, 2004
Vaccinating asthmatic children against influenza is unlikely to
protect them from attacks and may even worsen their condition, say
researchers who have found asthma-related emergency department visits are
significantly more likely among children who have received a flu shot.
The US study comes a week after Australian authorities said they would
consider whether local immunisation recommendations should be brought
into line with America's. Asthmatic children in the US are told to use
the vaccine but from September the recommendation will be extended to all
children aged between six months and two years. In Australia, influenza
immunisationis not recommended for all children; however, a universal
program is being considered by the Federal Government's vaccine advisory
panel.
Professor David Isaacs, a specialist in immunology and infectious
diseases at the Children's Hospital at Westmead and the chairman of the
Australian Technical Advisory Group on Immunisation's committee on
influenza, said: "In the United States they say children with asthma
should be given a vaccine against the flu because getting the flu could
make their asthma worse, but the evidence supporting this idea is far
from brilliant."
Professor Isaacs said previous studies had failed to show different rates
of asthma attack between groups of children give neither the vaccine or a
placebo. "People seem to assume the vaccine will be good [for asthmatics]
but the evidence does not show that it is," he said. "In fact, there are
lots of studies now suggesting it does not offer much benefit at all."
The American researchers compared two groups of 400 asthmatic children.
One group received the vaccine. Those who were vaccinated were found to
be almost twice as likely to seek assistance at an emergency department
because of their asthma.
However, one specialist says doctors and parents should not read too much
into the research. A medical virologist at Prince of Wales Hospital,
Associate Professor Bill Rawlinson, said the findings might only reflect
the higher use of the vaccine among children with severe asthma. "If you
are a more severe asthmatic, you are more likely to get the vaccine,"
he said.

Is infant immunization a risk factor for childhood
asthma or
allergy?
Kemp T, Pearce N, Fitzharris P, Crane J, Fergusson D, St George I,
Wickens K, Beasley R.
Department of Medicine, Wellington School of Medicine, New Zealand.
The Christchurch Health and Development Study comprises 1,265 children
born in 1977. The 23 children who received no diphtheria/pertussis/tetanus
(DPT) and polio immunizations had no recorded asthma episodes or
consultations for asthma or other allergic illness before age 10 years;
in the immunized children, 23.1% had asthma episodes, 22.5% asthma
consultations, and 30.0% consultations for other allergic illness.
Similar differences were observed at ages 5 and 16 years. These findings
do not appear to be due to differential use of health services (although
this possibility
cannot be excluded) or con-founding by ethnicity, socioeconomic status,
parental atopy, or parental smoking.
PMID: 9345669 [PubMed - indexed for MEDLINE

http://www.medscape.com/viewarticle/491744?src=mp
DELHI (Reuters Health) Oct 21 - A BCG scar size of less than five
millimeters is associated with an increased risk of developing asthma,
researchers from Brazil report.
The strong T-helper 1 lymphocyte (Th1) stimulating effect of BCG vaccine
and the Th1/Th2 imbalance hypothesis in the pathogenesis of asthma
prompted Dr. Rosangela de M. Queiroz and colleagues from the Federal
University of Pernambuco to examine the relationship between inoculation
scar size and asthma. The BCG scar diameter was measured by two
independent observers in ninety children with asthma and an equal number
of controls, all between 6 and 14 years of age.
The BCG scar was less than 5 mm in diameter in 28 (31.1%) asthmatic
children and in 11 (12.2%) controls, Dr. Queiroz and colleagues report in
the September issue of Indian Pediatrics. After accounting for all the
confounding factors, the asthmatic children were over three times more
likely to have a BCG scar smaller than 5 mm, the researchers calculate.
Decreased stimulation of Th1 cells could have resulted in a smaller BCG
scar and could have altered the Th1/Th2 relationship in favor of Th2
response, thus predisposing to asthma, Dr. Queiroz's team postulates.
"Perhaps the BCG vaccine merely prevents the development of atopic
illness in the absence of a strong genetic influence," they add. Low
levels of interferon gamma in mononuclear cells of patients with asthma
and the relationship between BCG scar size and interferon gamma levels
could explain the association between the two, the researchers write.
"The extent of Th1/Th2 balance during the neonatal period may be the key
determinant of how the genetic predisposition to asthma is modulated,"
Dr. Queiroz and colleagues conclude.
Indian Pediatr 2004;40:916-921.

Annals of Allergy, 1951; 9
"Cow's milk is one of the most frequent food allergens. Whole casein
appears to be highly allergenic...85% of the patients presented a
response to each of the four caseins. "
International Archives of Allergy and Immunology,
1998 Mar, 115:3

URL: http://www.msnbc.msn.com/id/8434572/
MSNBC
Surgeon general targets asthma 'epidemic'
Top U.S. doctor says thousands don't manage the disease appropriately
By Tom Costello
Correspondent
NBC News
July 1, 2005
A mobile asthma clinic in the inner city of Los Angeles is on a mission to
help kids breathe and keep them out of the emergency room. The clinic is on
the front lines in what doctors call the battle against an epidemic.
"The usual care for asthmatic kids in the inner city, or the frequent care,
is the emergency room," says Dr. Stanley Galant with Children's Hospital of
Orange County, Calif. The numbers, from the U.S. surgeon general, the
Centers for Disease
Control and the American Lung Association, are striking:
· 20 million Americans suffer from asthma - that's three times as many as
25 years ago; · 1 in every 8 children has asthma; · 12 people die from
asthma daily. "You will breathe and then ... like you're wheezing and
struggling to get it out, and then you breathe in quickly and then it
keeps on going and it gets really tight in your chest," says
14-year-old Michael Stampler as he describes his symptoms. Stampler's
asthma has landed him in the emergency room several times, even though he
conscientiously takes medicine daily and uses inhalers to keep his asthma at
bay. "The emergency room needs to be part of the plan," says Michael's
mother, Ann Stampler. "It needs to be plan B." But the surgeon general
says too many people fail to keep their asthma under control, then turn to
hospitals when they suffer an attack, with 5,000 ER visits recorded each
day.
"There is no cure for asthma, but it is a very manageable disease if you
understand the triggers in your life," says U.S. Surgeon General Dr. Richard
Carmona.
The Environmental Protection Agency has found that fewer than 30 percent
of people with asthma are taking simple steps to reduce exposure to those
triggers. Secondhand smoke, cockroaches, dust mites, mold and ozone can
cause asthma in young children or set off asthma attacks. Experts believe
that by helping patients manage their asthma more effectively and keeping
them out of the ER, they could save the health care system more than $500
million each year. The ultimate goal: Cutting asthma-related
hospitalizations by 50,000 over the next five years. "If one of my
patients ends up in the emergency room, that I view as a failure!"
says Dr. Ronald Ferdman at Children's Hospital Los Angeles. "We
believe that we should be able to keep everybody out of the emergency room."
Ferdman advocates early intervention and constant vigilance to keep a
killer at bay.
NOTE: The CDC states 1 in 8 have asthma. Another figure that is out of
control. This article mentions smoke, cockroaches and mold to be triggers
but haven't these been around forever. Why the increase? Seems they did not
mention the Study out of Otago University which claims antibiotics in the
first year of life is linked to asthma or the study published in
Epidemiology claiming a child who has received both the DPT and tetanus
vaccines is 50% more likely to develop asthma and 80% more likely to develop
sinusitis. Vaccinations cause autoimmune responses which is what asthma and
allergies are. The body is creating a huge amount of antibodies against
itself. To learn more about these conditions and ways to treat please join
us in Fort Pierce, Florida, August 13, 2005. For more info call ( 772 ) 873
0911
The E.C.H.O. Foundation
Educating on Children's Health Options

One in Six High School Students Reports Asthma
Friday, August 12, 2005
By Miranda Hitti
One in six U.S. high school students reports having asthma, and a third of
them note having an asthma episode or attack in the past year. Those numbers
appear in the CDC's Morbidity and Mortality Weekly Report. Data came from
anonymous surveys given to more than 13,000 students in grades 9-12
nationwide.
Overall, nearly 19 percent of the students stated that they had ever been
told by a doctor or nurse that they had asthma. Slightly fewer -- 16
percent, or about one in six -- noted current asthma. Of students reporting
current asthma, about 38 percent said they had had an asthma episode or
attack in the previous year. Those asthma attacks or episodes were more
often reported by girls and younger students (ninth graders). The reasons
for that aren't clear, states an editorial note from the CDC.
Hispanic students were less likely than blacks or whites to report current
or past asthma. About 15 percent of Hispanic students reported ever having
asthma, compared to 21 percent of blacks and 19 percent of whites.
The students' medical records were not checked to confirm their
self-reported asthma diagnoses. Many teachers -- and certainly school nurses
-- are familiar with helping children with asthma. Still it's important to
take steps to ensure that your child gets adequate attention and that all
the relevant people at school are familiar with what is needed to help your
child.
The findings underscore the need for health care providers, schools, and
families to be prepared to respond to asthma-related emergencies and help
students manage their asthma, writes the CDC.
By Miranda Hitti, reviewed by Brunilda Nazario, MD
SOURCES: Morbidity & Mortality Weekly Report, Aug. 12, 2005; vol 54: pp
765-767. News release, CDC. WebMD Medical Reference provided in
collaboration with The Cleveland Clinic: "Managing Your Child's Asthma at
School."
http://www.foxnews.com/story/0,2933,165450,00.html

Can Hib Vaccine Cause Asthma?
http://www.vaccination.org.uk/vaccines/hib2.html
Can Hib Vaccine Cause Asthma?
by Heidi White
Can the Haemophilus influenzae type b (Hib) vaccine cause asthma or allergy?
I am not aware of any human studies that have specifically looked at the
effect of Hib vaccine on asthma. However, a Swiss study1 found that invasive
Hib infection (epiglottitis) could possibly be linked to an increase in the
rate of asthma and allergies (OR 4.8). There may be a few explanations for
this. Firstly, the treatment of a Hib infection with antibiotics, such as
cephalosporins (eg cefotaxime or ceftriaxone),
may by itself increase the risk of asthma.2 And secondly, cell wall
components from the Hib bacteria may also be a cause of asthma.
If invasive Hib infection is able to cause asthma then it may also be
possible that the Hib vaccine could also have a similar effect. Animal
studies have provided various mechanisms for why this could occur:
a) A nasal Hib vaccine has been shown to stimulate Th1 and Th2 cells in
mice.3 If the Th2 side of the immune system is over stimulated, then this
can increase the risk of asthma and allergy.
b) Hib vaccination in rats has been shown to enhance histamine levels with a
corresponding increase in the number of eosinophils.4-7
Eosinophils (white blood cells, used to fight infection) will proliferate
and accumulate in the airways under stimulation by interleukin-5
(IL-5), a cytokine produced by Th2 cells. Eosinophil accumulation is also
evident in the dermis of the skin seen in people with atopic dermatitis
(eczema).
c) Hib vaccination in rats has been shown to cause increased
bronchoconstriction in response to histamine, possibly due to an increased
reactivity of the para-sympathetic/cholinergic
pathways.7,8
d) Studies in guinea-pigs have shown that Hib vaccination may impair the
beta (b ) 2-adrenergic system by causing a blocking or desensitization of b
2 receptors, or by reducing the number of b 2 receptors in the lung.9-13
Inhibition of b receptors can lead to increased bronchoconstriction.
It is thought that the polysaccharide component of the bacterial cell wall
may be responsible for this effect.14 HibTitre vaccine contains purified
polysaccharide (PRP), from the capsule of the Hib bacteria, which is linked
to a diphtheria carrier protein. PedvaxHIB vaccine contains PRP linked to a
meningococcal protein.
It would be interesting to see the results of a human study that
specifically examines the effects of Hib vaccine on the incidence of asthma
and allergy.
Heidi White
Hospital Pharmacist
September, 1999.
REFERENCES:
1. Muhlemann K et al. Risk factors for invasive Haemophilus influenzae
disease among children 2-16 years of age in the vaccine era, Switzerland
1991-1993. The Swiss H. Influenzae Study Group. Int J Epidemiol 1996
Dec;25(6):1280-5
2. Farooqi IS, Hopkin MH. Early childhood infection and atopic
disorder.Thorax 1998 November; 53: 927-932
3. Kurono Y et al. Nasal immunization induces Haemophilus influenzae-specific
Th1 and Th2 responses with mucosal IgA and systemic IgGantibodies for
protective immunity. J Infect Dis 1999 Jul;180(1):122-32
4. Nijkamp FP et al. Facilitation of histamine release in the Haemophilus
influenzae vaccinated experimental animal. Br J Pharmacol. 1980Jan;
68(1):147P
5. Raaijmakers JA, Terpstra GK, Kreukniet J. Mast cells as a possible source
of Haemophilus influenzae-induced changes in plasma and lunghistamine
levels. Int Arch Allergy Appl Immunol 1980;61(3):352-7
6. Terpstra GK, Raaijmakers JA; Kreukniet J. Comparison of vaccination of
mice and rats with Haemophilus influenzae and Bordetella pertussis as models
of atopy. Clin Exp Pharmacol Physiol 1979 Mar-Apr;6(2):139-49
7. Terpstra GK et al. Effects of Haemophilus influenzae vaccination on the (para-)sympathic-
cyclic nucleotide-histamine axis in rats.
Ann Allergy 1979 Jan; 42(1):36-40
8. Schreurs AJ, Nijkamp FP. Bronchial hyper-reactivity to histamine induced
by Haemophilus influenzae vaccination. Agents Actions 1984 Oct;15(3-4):
211-5
9. Terpstra GK, Kreukniet J, Raaijmakers JA. Changes in beta-adrenergic
responses as a consequence of infection with micro-organisms. Eur J Respir
Dis Suppl 1984;135:34-46
10. Schreurs AJ, Terpstra GK et al. The effects of Haemophilus influenzae
vaccination on anaphylactic mediator release and isoprenaline-induced
inhibition of mediator release. Eur J Pharmacol 1980 Apr 4;62(4):261-8
11. Schreurs AJ, Versteeg DH, Nijkamp FP. Involvement of catecholamines in
Haemophilus influenzae induced decrease of beta-adrenoceptor function.
Naunyn Schmiedebergs Arch Pharmacol 1982 Sep; 320(3):235-9
12. Schreurs AJ, Terpstra GK, Raaijmakers JA, Nijkamp FP. Effects of
vaccination with Haemophilus influenzae on adrenoceptor function of tracheal
and parenchymal strips. J Pharmacol Exp Ther 1980 Dec;215(3):691-6
13. Nijkamp FP et al. Inhibition of effects of isoprenaline and adrenaline
by Haemophilus influenzae vaccination. Br J Pharmacol. 1980 Jan;68(1):146P.
14. Schreurs AJ, Verhoef J, Nijkamp FP. Bacterial cell wall components
decrease the number of guinea-pig lung beta-adrenoceptors. Eur J Pharmacol
1983 Jan 28; 87(1):127-32
Journal articles--Hib vaccine & asthma
Back to page